Drug Topics December 2021

December 15, 2021

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.

December 14, 2021

As we head into 2022, the pharmaceutical industry still faces uncertainty stemming from supply chain challenges.

December 14, 2021

Overwhelmed pharmacists are no longer scared of speaking up to managers.

December 13, 2021

MyRx PRO is a comprehensive pharmacy management platform that streamlines workflows, increases optimization, and helps pharmacies maximize their bottom line through artificial intelligence–powered pricing intelligence.

December 13, 2021

From medication to legislation, multiple developments have advanced the pharmacy profession this year.

December 13, 2021

Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.

December 10, 2021

Pharmacists discuss the best methods for postoperative opioid prescription management.

December 10, 2021

Each autumn, Drug Topics® surveys its readers from across the country to take the pulse of the pharmacy profession before heading into the new year. This year, 1123 respondents were more eager than perhaps ever before to share their feelings on important workplace issues.

December 10, 2021

Highlights included updates on COVID-19 vaccine tolerance in individuals with rheumatic diseases, the latest data on medical cannabis use in fibromyalgia, and more.

December 09, 2021

The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.

December 08, 2021

Questions continue to swirl around eligibility for these shots.

December 08, 2021

Influenza is expected to make a comeback this year, and no one knows how severe it may be.

December 08, 2021

Mobile apps and fitness trackers predate the COVID-19 pandemic but are being utilized more ever before.